Form 10-Q · Quarterly report
Sherwin-Williams 10-Q, filed Jul 28, 2026
- Filed
- CIK
- 0000089800
- Accession no.
- 0000089800-26-000049
Summary
Sherwin-Williams reported second-quarter 2026 net sales of $6.7893 billion, up 7.5% from a year earlier, with growth across all reportable segments and help from the October 2025 acquisition of Suvinil. Income before income taxes rose to $1.1125 billion from $985.7 million, while gross margin slipped to 49.2% from 49.4%.
Key points
- Second-quarter net sales rose 7.5% to $6.7893 billion, with Paint Stores Group up 5.1%, Consumer Brands Group up 21.5%, and Performance Coatings Group up 6.3%.
- Second-quarter income before income taxes was $1.1125 billion, up from $985.7 million a year earlier, while gross margin slipped to 49.2% from 49.4%.
- The October 2025 acquisition of Suvinil contributed to Consumer Brands Group growth and to the increase in consolidated foreign subsidiary sales, led by Latin America.
- Six-month net sales rose 7.2% to $12.4562 billion, and six-month income before income taxes was $1.7923 billion versus $1.6387 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. MANAGEMENT’S DISCUSSION RESULTS OF OPERATIONS The Company has historically experienced, and expects to continue to experience, variability in quarterly results. The results of operations for the three and six months ended June 30, 2026 are not indicative of the results to be expected for the full year as our business is seasonal in nature, with the majority of Net sales for the Reportable Segments traditionally occurring during the second and third quarters. However, periods of economic uncertainty can alter the Company’s seasonal patterns. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.